Literature DB >> 1954373

Production of erythropoietic bursts by progenitor cells from adult human peripheral blood in an improved serum-free medium: role of insulinlike growth factor 1.

P N Correa1, A A Axelrad.   

Abstract

Several culture media for the growth of human circulating erythroid burst-forming units (BFU-E) that have been claimed to be "serum-free" ("SF") have actually included albumin preparations known to be contaminated with an undefined burst-promoting activity (BPA); a BPA has also been found in the preparations of other "SF" medium components. This has precluded reliable investigation of the growth factor (GF) requirements of these progenitors. Using a defatted, BPA-free bovine serum albumin (BSA) and the recombinant human growth factors (GFs) erythropoietin (rHu Epo), insulinlike growth factor 1 (rHu IGF-1), and interleukin-3 (rHu IL-3), we have developed an improved serum-free (SF) medium for the production of erythroid bursts from normal adult human peripheral blood mononuclear cells (PBMNC), which requires both hemin and retinyl acetate for its optimal performance. In the presence of BSA without IL-3 or Epo, no burst or colony formation was observed. With IL-3 and Epo alone, only a small number of day 14 erythroid colonies was obtained (12 +/- 1/10(5) PBMNC). Addition of hemin (0.1 mmol/L) allowed the direct scoring of day 14 hemoglobinized colonies and increased their number sevenfold (86 +/- 5). Inclusion of retinyl acetate at physiologic concentrations further augmented the number of colonies threefold to fourfold. Under these apparently optimal conditions, we found that IGF-I could entirely replace Epo. However, IGF-I required a 100-fold higher molar concentration than that of Epo to reach maximal stimulation. The combined effect of Epo and IGF-I was found to be less than the sum of their individual effects, suggesting an overlap in the sensitivities of erythroid progenitors to these GFs. The colony-forming efficiencies of erythroid progenitors in the improved SF medium was very high: 700 single, day 14 erythroid colonies/10(5) PB MNC (at 0.25 mmol/L hemin) distributed as 126 clusters (bursts), with a mean of 5.6 component colonies per burst. These findings show that IGF-I has an Epo-like activity that targets circulating early erythroid progenitors or their progeny, providing strong evidence for the existence of an Epo-independent pathway for normal human adult erythropoiesis, possibly operative when Epo levels are low.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1954373

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Ames hypopituitary dwarf mice demonstrate imbalanced myelopoiesis between bone marrow and spleen.

Authors:  Maegan L Capitano; Brahmananda R Chitteti; Scott Cooper; Edward F Srour; Andrzej Bartke; Hal E Broxmeyer
Journal:  Blood Cells Mol Dis       Date:  2015-03-28       Impact factor: 3.039

2.  Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection: molecular characteristics and functional competence.

Authors:  Claudia Filippone; Rauli Franssila; Arun Kumar; Leena Saikko; Panu E Kovanen; Maria Söderlund-Venermo; Klaus Hedman
Journal:  PLoS One       Date:  2010-03-02       Impact factor: 3.240

3.  Accurate processing and secretion in the baculovirus expression system of an erythroid-cell-stimulating factor consisting of a chimaera of insulin-like growth factor II and an insect insulin-like peptide.

Authors:  L F Congote; Q Li
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

4.  A reappraisal of the role of insulin-like growth factor I in the regulation of human hematopoiesis.

Authors:  M Z Ratajczak; W I Kuczynski; K Onodera; J Moore; J Ratajczak; D A Kregenow; K DeRiel; A M Gewirtz
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

5.  Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells.

Authors:  K Muta; S B Krantz; M C Bondurant; A Wickrema
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

6.  Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus.

Authors:  M E Garay-Sevilla; L E Nava; J M Malacara; K Wróbel; K Wróbel; U Pérez
Journal:  Diabetes Metab Res Rev       Date:  2000 Mar-Apr       Impact factor: 8.128

7.  Colony growth of human hematopoietic progenitor cells in the absence of serum is supported by a proteinase inhibitor identified as antileukoproteinase.

Authors:  H M Goselink; J van Damme; P S Hiemstra; A Wuyts; J Stolk; W E Fibbe; R Willemze; J H Falkenburg
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

8.  A polymorphism at IGF1 locus is associated with anemia.

Authors:  Maria Adelaide Marini; Gaia Chiara Mannino; Teresa Vanessa Fiorentino; Francesco Andreozzi; Francesco Perticone; Giorgio Sesti
Journal:  Oncotarget       Date:  2017-05-16

9.  Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors.

Authors:  F Galimi; G P Bagnara; L Bonsi; E Cottone; A Follenzi; A Simeone; P M Comoglio
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

10.  Assessment of hematopoietic failure due to Rpl11 deficiency in a zebrafish model of Diamond-Blackfan anemia by deep sequencing.

Authors:  Zhaojun Zhang; Haibo Jia; Qian Zhang; Yang Wan; Yang Zhou; Qiong Jia; Wanguang Zhang; Weiping Yuan; Tao Cheng; Xiaofan Zhu; Xiangdong Fang
Journal:  BMC Genomics       Date:  2013-12-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.